UV-C LIGHTS (HVAC-UV Light Sanitizer) OVERVIEW
What is UV Light?
This type of light is naturally emitted by the sun, but it can also be generated artificially by lamps and light fixtures. Within the spectrum of sunlight, the light with a wavelength of 100 to 400 nanometers (nm) is called ultraviolet light. It can be divided into UV-A (315 to 400 nm), UV-B (280 to 315 nm), and UV-C (200 to 280 nm). Unlike with regular fluorescent light tube products, which allow us to visually confirm light brightness, assessing light intensity on a UV lighting device is more complicated, as UV light is invisible to the naked eye.
For decades, the scientific community has been aware about the disinfection ability of ultraviolet light (UV) wavelengths.
As mentioned above, UV wavelengths can range anywhere from 100 to 400 nm, and comprise distinct spectra. UV-A and UV-B have a spectrum range higher than 300 nm, which fails to inactivate pathogens, rendering them ineffective for disinfection applications. However, UV-C light falls between 200 and 280 nm (peak at 250-275 nm) and bears the ability to kill pathogens. Also known as germicidal light, this UV range includes far-UV-C radiation and UV-C radiation. Far UV-C is currently been tested to guarantee its safety on skin and eyes, and has a range of 207 to 222 nm.
How UV-C Works
With the rapid development of UV-C applications for disinfection purposes, there is a growing need to quantify and determine if a UV-C lamp or setup will accomplish the desired results.
Research has shown that DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) absorb ultraviolet radiation most readily at wavelengths between 254 and 275 nm. Since UV-C falls within this range, UV-C technology is capable to penetrate the cell membrane and nucleus of pathogens.
When the DNA and RNA in the cells of a pathogen are exposed to UV-C radiation, a chemical change occurs in the nucleic acids, resulting in a corruption in the genetic code. During this process, called dimerization, UV-C radiation inactivates the pathogen by causing cellular inability to regenerate or replicate, or by causing cell death.
Due to this ability, UV-C light is also known as germicidal UV, and has been proven to successfully neutralize the effect of a variety of pathogens, such as bacterial propagules, spores, viruses, fungi, etc.
Why Choose UV Sanitizer
The Illuminating Engineering Society (IES) has released a new report on Germicidal Ultraviolet (GUV) light and how it could reduce the spread of COVID-19. With the right equipment, germicidal UV can successfully and safely be used to disinfect air in occupied spaces, such as hospital waiting rooms, intensive care units and operating rooms, as well as clinics, offices, manufacturing and transportation facilities, schools, houses, etc.
In unoccupied controlled-access environments, UV-C can be used as a supplemental measure to disinfect room surfaces, greatly reducing the spread of healthcare-associated contamination. Germicidal UV-C is also currently being used for the disinfection of certain types of personal protective equipment (PPE) for limited reuse during the pandemic.
AMTEK helps you to breathe safer in a healthier environment
How UV-C is measured
- Irradiance
Irradiance is the flux of radiant energy per unit area (normal to the direction of flow of radiant energy through a medium).
It is a way to measure how much [light density of radiation incident on a given surface area] total UV-C energy has irradiated a surface at certain distance. Irradiance is expressed in microwatts per square centimeter per distance (μW•S /cm2 •distance).
This measurement can be used to evaluate both the efficacy and safety of a device.
The relationship between irradiance and source-surface distance can be expressed by the inverse square law in which the peak intensity on a surface decreases exponentially with distance.
The real value would require taking into account the viewing angle, radiation pattern, area of interest on the surface, and other external factors such as potential reflection from the environment.
IRRADIANCE map using 250 Watts UV-C lamp
- Fluence
Fluence is another way to measure how much total UV-C energy has irradiated a surface during a certain amount of time. It is also sometimes referred to as UV-C dosage or UV-C exposure dosage.
A key component of successful UV-C disinfection is ensuring the pathogen is exposed to the right light fluence (UV-C dosage) so the UV-C radiation can be absorbed through its membrane. In fact, this is the most crucial element in UV-C system design, because fluence is the primary determinant to successful pathogen inactivation. Different pathogens will require different doses of UV-C light to be killed or inactivated.
Fluence is expressed in milijoules per cm2 (mJ/cm2) and is the dosage of UV-C exposure required to neutralize a specific pathogen. Calculated for water, surface, and air disinfection the formula is:
UV-C irradiance (μW/cm2) × exposure time (seconds)
The fluence value can be augmented by
1) Increasing the strength of the UV-C light source wattage generated,
2) Increasing the time/exposure to the UV-C light source or,
3) By decreasing the distance between UV-C light source and the object to be disinfected.
FLUENCE map using 250 Watts UV-C lamp with 10 minutes
- What Fluence Is Required?
This depends on the following factors:
• Kind of pathogens to be treated
• Level of disinfection / log reduction
• UV wavelength(s) delivered
• Time
The degree of pathogen inactivation by ultraviolet radiation is directly related to the UV-C dose applied. This dose is the product of UV-C irradiance (I, as expressed as energy per unit surface area) and exposure time (T). Therefore: DOSE = I x T.
The UV-C dose required does depend on the task and/or the situation.
- Log Reduction
It is essential to understand what logarithmic (log) reduction is and why it is important to the process of surface disinfection. Scientists, engineers, and other professionals who are responsible, sometimes even legally, for preventing illness and pathogenic contamination, use log reduction as a measure to evaluate the level of elimination of the microbial bio-burden.
The term log is short for logarithm, a mathematical term for a power to which a number can be raised. For example, using 10 as the given number, a log 2 increase can be shown as 102 or 10 x 10 = 100.
Once the log value is obtained, the reduction of microorganisms is calculated using a logarithmic scale as shown on the graphic below.
This table is an example of log reduction values using a starting point of one (1) million bacteria or 1,000,000 CFU’s on a surface (i.e.: under bed rails in a hospital), as outlined below:
NOTE: The UV-C exposure dosage needed for each level of reduction is shown on Appendix A (Tables) along with the published reference in Appendix C (References), where the data came from.
Why Log Reduction is important.
Hospital surfaces can be contaminated with pathogenic organisms, and achieving a reduction of only 6.0 log or below means enough cells of dangerous viruses, bacteria, fungus, or Clostridium difficile (C. diff) spores, can or will be left behind to proliferate and repopulate surfaces within the treated area.
Literature shows that pathogens can be spread, contaminate patients, and/or grow new bacterial and fungal colonies on new surfaces (Koganti, S. & Donskey, C., 2016).
The number of pathogen survivors is very important because they can increase their populations exponentially in a very short time. For example, Staphylococcus aureus (S. aureus), under ideal conditions, doubles its colony size in 24-30 minutes (Generation Time, G). This means 1,000 (or 103 or log 3) pathogen individuals would increase to 2,000 after 30 minutes, 60 minutes later they would have increased to 4,000, and after two hours to 16,000 and then to over one million (1,024,000) after 5 hours or more, if the growing environment is optimal.
Log Reduction Examples for Clostridium Difficile (C. diff) Spores
A UV-C product was shown by Cadnum & Donskey (2016) to achieve a low reduction of about 3.3 log on an inoculated surface placed at four (4) feet away from the light source and after a 40 min exposure. In this case, only surfaces exposed in a favorable manner were tested on (i.e.: facing light source and 4 ft or less away from it) (Cadnum, J. L., Donskey, C., 2016).When calculating a reduction of 3.3 log, if the surface is contaminated with 1,000,000 spores, that means there will be more than 100 C. difficile survivors remaining that can repopulate surfaces and infect people.
Another UV-C light product was shown by Dr. J. Boyce, MD (2016) to achieve a log reduction range of 2.0 – 4.0 for C. difficile, after a manufacturer recommend a fifteen (15) minute treatment on an inoculated surface at a zero (0) degree angle to the light, and only four (4) feet from the light source (Boyce, J.M., 2016).
When calculating a log reduction of 2.0 – 4.0, if the surface is contaminated with 1,000,000 spores, that means there will be between about 100 to 10,000 C. difficile survivors remaining.Evidently, none of the examples above achieve disinfection, decontamination, or sterilization.
UV-C LAMP TECHOLOGY
Induction Lamp Technology
Advantages of Magnetic Induction Technology
Quartz lamp made in Japan
Long life lamp > 50,000 hrs.
Zero maintenance cost
254 nm perfect spectrum
185 nm to get Ozone output
Suitable for large spaces
Movable and easy to use device
Working temperature from -20˚C to +100˚C
Capability of working under water at 50cm. depth
LED Lamp Technology
With the development of better chips and components, UV-C LED technology is in constant progress. Nonetheless, as was the case with LED lighting from a few years back, today UV-A, UV-B, and UV-C LEDs aren’t yet as powerful as linear and induction technology tubes. However, there are many applications in which UV-C LED technology at close range is very reliable. Additionally, UV-C LEDs are able to generate a more precise UV-C spectrum than linear and induction lamps. UV-C LEDs generally work at 260 – 280 nm.
Today, technologically advanced UV-C LED devices such as Hand-Rail disinfection units for electric stairs, counterfeit detection systems, low-power equipment sterilizers, and portable curing and coating methods offer great application possibilities to users. Initially used predominantly in the printing industry, the UV-C LED is today being used in a variety of fields: medical, automotive, security, electronics, and more.
Electrical Stairs Handrail LED UV-C disinfection device
UV-C Light Applications
Water
- Water plants purification
- Water wells & water cisterns
- Households under sink installations
- Ice making machines
- Water vending machines
- Laundry water
- Schools, restaurants, airports and hotels
- Aquarium, hatcheries, and nurseries
- Swimming pools & hot tubs
- Farms, ranches & trailer parks
- Boats & recreational vehicles
Food Processing
- Food processing (processing, warehousing, handling, production dept., salad bars, buffets, bakeries, restaurants), meat, poultry, dairy -agriculture plants
- Bottling facilities
- Soft & fruit drinks, and juices
- Brewery & winery
Medical
- Laboratories, hospitals, and clinics
- Pharmaceutical production
- Pathology labs, kidney dialysis
- Agriculture (animal husbandry)
Industries
- Cosmetics and electronic production
- Metal & mechanic plants
- Biotech industry (research labs, biotech labs, equipment sterilization)
- Public & private ground [buses, vehicles, trains, sub-ways, trucks] and air [aircraft cabins, airports] transportation disinfection
- Clean rooms
- Public toilets
- Printing
- Personal UV-C disinfections units
- HAVC systems (commercial, industrial, healthcare, and residential)
- Water treatment plants
- Banks money disinfection
- Lake & pond reclamation
UV-C Light Features and Benefits
- Environmentally friendly, no dangerous or toxic chemicals on the air or water
- Effective Germicidal Wavelength
- Effective Eradication of Most Spores
- Covering Large Production Capacity of UV-C light disinfection.
- UV treatment is highly compatible with other treatment processes
- Cost effective, low initial capital costs and reduced operating costs
- Flexible design capabilities for custom lamp system development
- Equipment with wide Operating Temperature
APPENDIX A: Tables
Table 1. UV Doses for Multiple Log Reductions for Various Spores
Spore | Lamp Type | UV Dose (Fluence) (mJ/cm2) for a given Log Reduction without photo-reactivation | Reference | ||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | |||
Bacillus subtilis ATCC6633 | N/A | 36 | 48.6 | 61 | 78 | Chang et al. 1985 | |||
Bacillus subtilis ATCC6633 | LP | 24 | 35 | 47 | 79 | Mamane-Gravetz and Linden 2004 | |||
Bacillus subtilis ATCC6633 | LP | 22 | 38 | >50 | Sommer et al. 1998 | ||||
Bacillus subtilis ATCC6633 | LP | 20 | 39 | 60 | 81 | Sommer et al. 1999 | |||
Bacillus subtilis WN626 | LP | 0.4 | 0.9 | 1.3 | 2 | Marshall et al., 2003 |
Table 2. UV Doses for Multiple Log Reductions for Various Bacteria
Bacterium | Lamp Type | UV Dose (Fluence) (mJ/cm2) for a given Log Reduction without photo-reactivation | Reference | ||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | |||
Aeromonas hydrophila ATCC7966 | LP | 1.1 | 2.6 | 3.9 | 5 | 6.7 | 8.6 | Wilson et al. 1992 | |
Aeromonas salmonicida | LP | 1.5 | 2.7 | 3.1 | 5.9 | Liltved and Landfald 1996 | |||
Campylobacter jejuni ATCC 43429 | LP | 1.6 | 3.4 | 4 | 4.6 | 5.9 | Wilson et al. 1992 | ||
Citrobacter diversus | LP | 5 | 7 | 9 | 11.5 | 13 | Giese and Darby 2000 | ||
Citrobacter freundii | LP | 5 | 9 | 13 | Giese and Darby 2000 | ||||
Escherichia coli ATCC 11229 | N/A | 2.5 | 3 | 3.5 | 5 | 10 | 15 | Harris et al. 1987 | |
Escherichia coli ATCC 11229 | N/A | 3 | 4.8 | 6.7 | 8.4 | 10.5 | Chang et al. 1985 | ||
Escherichia coli ATCC 11229 | LP | <5 | 5.5 | 6.5 | 7.7 | 10 | Zimmer et al. 2002 | ||
Escherichia coli ATCC 11229 | MP | <3 | <3 | <3 | <3 | 8 | Zimmer et al. 2002 | ||
Escherichia coli ATCC 11229 | LP | 7 | 8 | 9 | 11 | 12 | Hoyer 1998 | ||
Escherichia coli ATCC 11229 | LP | 3.5 | 4.7 | 5.5 | 6.5 | 7.5 | 9.6 | Sommer et al. 2000 | |
Escherichia coli ATCC 11229 | LP | 6 | 6.5 | 7 | 8 | 9 | 10 | Sommer et al. 1998 | |
Escherichia coli ATCC 11303 | LP | 4 | 6 | 9 | 10 | 13 | 15 | 19 | Wu et al. 2005 |
Escherichia coli ATCC 25922 | LP | 6 | 6.5 | 7 | 8 | 9 | 10 | Sommer et al. 1998 | |
Escherichia coli C | LP | 2 | 3 | 4 | 5.6 | 6.5 | 8 | 10.7 | Otaki et al. 2003 |
Escherichia coli O157:H7 | LP | 1.5 | 3 | 4.5 | 6 | Tosa and Hirata 1999 | |||
Escherichia coli O157:H7 | LP | <2 | <2 | 2.5 | 4 | 8 | 17 | Yaun et al. 2003 | |
Escherichia coli O157:H7 CCUG 29193 | LP | 3.5 | 4.7 | 5.5 | 7 | Sommer et al. 2000 | |||
Escherichia coli O157:H7 CCUG 29197 | LP | 2.5 | 3 | 4.6 | 5 | 5.5 | Sommer et al. 2000 | ||
Escherichia coli O157:H7 CCUG 29199 | LP | 0.4 | 0.7 | 1 | 1.1 | 1.3 | 1.4 | Sommer et al. 2000 | |
Escherichia coli O157:H7 ATCC 43894 | LP | 1.5 | 2.8 | 4.1 | 5.6 | 6.8 | Wilson et al. 1992 | ||
Escherichia coli O25:K98:NM | LP | 5 | 7.5 | 9 | 10 | 11.5 | Sommer et al. 2000 | ||
Escherichia coli O26 | LP | 5.4 | 8 | 10.5 | 12.8 | Tosa and Hirata 1999 | |||
Escherichia coli O50:H7 | LP | 2.5 | 3 | 3.5 | 4.5 | 5 | 6 | Sommer et al. 2000 | |
Escherichia coli O78:H11 | LP | 4 | 5 | 5.5 | 6 | 7 | Sommer et al. 2000 | ||
Escherichia coli K-12 IFO3301 | LP&MP | 2 | 4 | 6 | 7 | 8.5 | Oguma et al. 2002 | ||
Escherichia coli K-12 IFO3301 | LP&MP | 2.2 | 4.4 | 6.7 | 8.9 | 11.0 | Oguma et al. 2004 | ||
Escherichia coli K-12 IFO3301 | LP | 1.5 | 2 | 3.5 | 4.2 | 5.5 | 6.2 | Otaki et al. 2003 | |
Escherichia coli Wild type | LP | 4.4 | 6.2 | 7.3 | 8.1 | 9.2 | Sommer et al. 1998 |
Table 3. UV Doses for Multiple Log Reductions for Various Protozoa
Protozoan | Lamp Type | UV Dose (Fluence) (mJ/cm2) for a given Log Reduction without photo-reactivation | Reference | ||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | |||
Cryptosporidium hominis | LP & MP | 3 | 5.8 | Johnson et al. 2005 | |||||
Cryptosporidium parvum, oocysts, tissue culture assay | N/A | 1.3 | 2.3 | 3.2 | Shin et al. 2000 | ||||
Cryptosporidium parvum | LP & MP | 2.4 | <5 | 5.2 | 9.5 | Craik et al. 2001 | |||
Cryptosporidium parvum | MP | <5 | <5 | <5 | ~6 | Amoah et al. 2005 | |||
Cryptosporidium parvum | MP | <10 | <10 | <10 | Belosevic et al. 2001 | ||||
Cryptosporidium parvum | LP | 1 | 2 | <5 | Shin et al. 2001 | ||||
Cryptosporidium parvum | MP | 1 | 2 | 2.9 | 4 | Bukhari et al. 2004 | |||
Cryptosporidium parvum | LP | <2 | <2 | <2 | <4 | <10 | Clancy et al. 2004 | ||
Cryptosporidium parvum | MP | <3 | <3 | 3-9 | <11 | Clancy et al. 2000 | |||
Cryptosporidium parvum | LP | <3 | <3 | 3-6 | <16 | Clancy et al. 2000 | |||
Cryptosporidium parvum | LP | 0.5 | 1 | 1.4 | 2.2 | Morita et al. 2002 | |||
Cryptosporidium parvum | LP | 2 | <3 | <3 | Zimmer et al. 2003 | ||||
Cryptosporidium parvum | MP | <1 | <1 | <1 | Zimmer et al. 2003 | ||||
Encephalitozoon cuniculi, microsporidia | LP | 4 | 9 | 13 | Marshall et al. 2003 | ||||
Encephalitozoon hellem, microsporidia | LP | 8 | 12 | 18 | Marshall et al. 2003 | ||||
Encephalitozoon intestinalis, microsporidia | LP & MP | <3 | 3 | <6 | 6 | Huffman et al. 2002 | |||
Encephalitozoon intestinalis, microsporidia | LP | 3 | 5 | 6 | Marshall et al. 2003 | ||||
Giardia lamblia, gerbil infectivity assay | LP | <0.5 | <0.5 | <0.5 | <1 | Linden et al. 2002b | |||
Giardia lamblia | LP | <10 | ~10 | <20 | Campbell et al. 2002 | ||||
Giardia lamblia | LP | <2 | <2 | <4 | Mofidi et al. 2002 | ||||
Giardia lamblia,excystation assay | N/A | > 63 | Rice and Hoff 1981 | ||||||
Giardia lamblia, excystation assay | N/A | 40 | 180 | Karanis et al. 1992 | |||||
Giardia muris, excystation assay | N/A | 77 | 110 | Carlson et al. 1985 | |||||
G. muris, cysts, mouse infectivity assay | N/A | <2 | <6 | 10 + tailing | Craik et al. 2000 | ||||
Giardia muris | MP | 1 | 4.5 | 28 + tailing | Craik et al. 2000 | ||||
Giardia muris | MP | <10 | <10 | <25 | ~60 | Belosevic et al. 2001 | |||
Giardia muris | LP | <1.9 | <1.9 | ~2 | ~2.3 | Hayes et al. 2003 | |||
Giardia muris | LP | <2 | <2 | <4 | Mofidi et al. 2002 | ||||
G. muris, cysts | MP | <5 | <5 | 5 | Amoah et al. 2005 |
Table 4. UV Doses for Multiple Log Reductions for Various Viruses
Virus | Host | Lamp Type | UV Dose (Fluence) (mJ/cm2) per Log Reduction | Reference | |||||
1 | 2 | 3 | 4 | 5 | 6 | ||||
PRD-1 (Phage) | S. typhimurium Lt2 | N/A | 9.9 | 17.2 | 23.5 | 30.1 | Meng and Gerba 1996 | ||
B40-8 (Phage) | B. Fragilis | LP | 11 | 17 | 23 | 29 | 35 | 41 | Sommer et al. 2001 |
B40-8 (Phage) | B. fragilis HSP-40 | LP | 12 | 18 | 23 | 28 | Sommer et al 1998 | ||
MS2 (Phage) | Salmonella typhimurium WG49 | N/A | 16.3 | 35 | 57 | 83 | 114 | 152 | Nieuwstad and Havelaar 1994 |
Virus | Host | Lamp Type | UV Dose (Fluence) (mJ/cm2) per Log Reduction | Reference | |||||
1 | 2 | 3 | 4 | 5 | 6 | ||||
MS2 DSM 5694 (Phage) | E. coli NCIB 9481 | N/A | 4 | 16 | 38 | 68 | 110 | Wiedenmann et al. 1993 | |
MS2 ATCC 15977-B1 (Phage) | E. coli ATCC 15977–B1 | LP | 15.9 | 34 | 52 | 71 | 90 | 109 | Wilson et al. 1992 |
MS2 NCIMB 10108 (Phage) | Salmonella typhimurium WG49 | N/A | 12.1 | 30.1 | Tree et al. 1997 | ||||
MS2 (Phage) | E. coli K-12 Hfr | LP | 21 | 36 | Sommer et al. 1998 | ||||
MS2 (Phage) | E. coli CR63 | N/A | 16.9 | 33.8 | Rauth 1965 | ||||
MS2 (Phage) | E. coli 15977 | N/A | 13.4 | 28.6 | 44.8 | 61.9 | 80.1 | Meng and Gerba 1996 | |
MS2 (Phage) | E. coli C3000 | N/A | 35 | Battigelli et al. 1993 | |||||
MS2 (Phage) | E. coli ATCC 15597 | N/A | 19 | 40 | 61 | Oppenheimer et al. 1993 | |||
MS2 (Phage) | E. coli C3000 | LP | 20 | 42 | 69 | 92 | Batch et al. 2004 | ||
MS2 (Phage) | E. coli ATCC 15597 | LP | 20 | 42 | 70 | 98 | 133 | Lazarova and Savoye 2004 | |
MS2 (Phage) | E. coli ATCC 15977 | LP | 20 | 50 | 85 | 120 | Thurston-Enriquez et al., 2003 | ||
MS2 (Phage) | E. coli HS(pFamp)R | LP | 45 | 75 | 100 | 125 | 155 | Thompson et al. 2003 | |
MS2 (Phage) | E. coli C3000 | LP | 20 | 42 | 68 | 90 | Linden et al. 2002a | ||
MS2 (Phage) | E. coli K-12 | LP | 18.5 | 36 | 55 | Sommer et al. 2001 | |||
MS2 (Phage) | E. coli NCIMB 9481 | N/A | 14 | Tree et al. 2005 | |||||
PHI X 174 (Phage) | E. coli WG5 | LP | 2.2 | 5.3 | 7.3 | 10.5 | Sommer et al. 1998 | ||
PHI X 174 (Phage) | E. coli C3000 | N/A | 2.1 | 4.2 | 6.4 | 8.5 | 10.6 | 12.7 | Battigelli et al. 1993 |
PHI X 174 (Phage) | E. coli ATCC15597 | N/A | 4 | 8 | 12 | Oppenheimer et al. 1993 | |||
PHI X 174 (Phage) | E. coli WG 5 | LP | 3 | 5 | 7.5 | 10 | 12.5 | 15 | Sommer et al. 2001 |
PHI X 174 (Phage) | E. coli ATCC 13706 | LP | 2 | 3.5 | 5 | 7 | Giese and Darby 2000 | ||
Staphylococcus aureus phage A 994 (Phage) | Staphylococcus aureus 994 | LP | 8 | 17 | 25 | 36 | 47 | Sommer et al. 1989 | |
Calicivirus canine | MDCK cell line | LP | 7 | 15 | 22 | 30 | 36 | Husman et al. 2004 | |
Calicivirus feline | CRFK cell line | LP | 7 | 16 | 25 | Husman et al. 2004 | |||
Calicivirus feline | CRFK cell line | N/A | 4 | 9 | 14 | Tree et al. 2005 | |||
Calicivirus feline | CRFK cell line | LP | 5 | 15 | 23 | 30 | 39 | Thurston-Enriquez et al. 2003 | |
Adenovirus type 2 | A549 cell line | LP | 20 | 45 | 80 | 110 | Shin et al. 2005 | ||
Adenovirus type 2 | Human lung cell line | LP | 35 | 55 | 75 | 100 | Ballester and Malley 2004 | ||
Adenovirus type 2 | PLC / PRF / 5 cell line | LP | 40 | 78 | 119 | 160 | 195 | 235 | Gerba et al. 2002 |
Adenovirus type 15 | A549 cell line (ATCC CCL-185) | LP | 40 | 80 | 122 | 165 | 210 | Thompson et al. 2003 | |
Adenovirus type 40 | PLC / PRF / 5 cell line | LP | 55 | 105 | 155 | Thurston-Enriquez et al. 2003 | |||
Adenovirus type 40 | PLC / PRF / 5 cell line | LP | 30 | ND | ND | 124 | Meng and Gerba 1996 | ||
Adenovirus type 41 | PLC / PRF / 5 cell line | LP | 23.6 | ND | ND | 111.8 | Meng and Gerba 1996 | ||
Poliovirus Type 1 ATCC Mahoney | N/A | N/A | 6 | 14 | 23 | 30 | Harris et al. 1987 | ||
Poliovirus Type 1 LSc2ab () | MA104 cell | N/A | 5.6 | 11 | 16.5 | 21.5 | Chang et al. 1985 |
Poliovirus Type 1 LSc2ab | BGM cell | LP | 5.7 | 11 | 17.6 | 23.3 | 32 | 41 | Wilson et al. 1992 |
Poliovirus 1 | BGM cell line | N/A | 5 | 11 | 18 | 27 | Tree et al. 2005 | ||
Poliovirus 1 | CaCo2 cell-line (ATCC HTB37) | LP | 7 | 17 | 28 | 37 | Thompson et al. 2003 | ||
Poliovirus 1 | BGM cell line | LP | 8 | 15.5 | 23 | 31 | Gerba et al. 2002 | ||
Poliovirus Type Mahoney | Monkey kidney cell line Vero | LP | 3 | 7 | 14 | 40 | Sommer et al. 1989 | ||
Coxsackievirus B5 | Buffalo Green Monkey cell line | N/A | 6.9 | 13.7 | 20.6 | Battigelli et al. 1993 | |||
Coxsackievirus B3 | BGM cell line | LP | 8 | 16 | 24.5 | 32.5 | Gerba et al. 2002 | ||
Coxsackievirus B5 | BGM cell line | LP | 9.5 | 18 | 27 | 36 | Gerba et al. 2002 | ||
Reovirus-3 | Mouse L-60 | N/A | 11.2 | 22.4 | Rauth 1965 | ||||
Reovirus Type 1 Lang strain | N/A | N/A | 16 | 36 | Harris et al. 1987 | ||||
Rotavirus SA-11 | Monkey kidney cell line MA 104 | LP | 8 | 15 | 27 | 38 | Sommer et al. 1989 | ||
Rotavirus SA-11 | MA-104 cell line | N/A | 7.6 | 15.3 | 23 | Battigelli et al. 1993 | |||
Rotavirus SA-11 | MA-104 cell line | N/A | 7.1 | 14.8 | 25 | Chang et al. 1985 | |||
Rotavirus SA-11 | MA-104 cell line | LP | 9.1 | 19 | 26 | 36 | 48 | Wilson et al. 1992 | |
Rotavirus | MA104 cells | LP | 20 | 80 | 140 | 200 | Caballero et al. 2004 | ||
Hepatitis A HM175 | FRhK-4 cell | LP | 5.1 | 13.7 | 22 | 29.6 | Wilson et al. 1992 | ||
Hepatitis A | HAV/HFS/GBM | N/A | 5.5 | 9.8 | 15 | 21 | Wiedenmann et al. 1993 | ||
Hepatitis A HM175 | FRhK-4 cell | N/A | 4.1 | 8.2 | 12.3 | 16.4 | Battigelli et al. 1993 | ||
Echovirus I | BGM cell line | LP | 8 | 16.5 | 25 | 33 | Gerba et al. 2002 | ||
Echovirus II | BGM cell line | LP | 7 | 14 | 20.5 | 28 | Gerba et al. 2002 |
APPENDIX B: UV-C Disinfection Background
Below are some key contributions over the years to the study of microorganisms and their response to UV-C light in the form of germicidal lamps.
1845 – It became known that microorganisms respond to light.
1855 – Arloing and Daclaux demonstrated that sunlight killed Bacillus anthracis and Tyrothrix scaber.
1877 – Downes and Blunt reported that bacteria were inactivated by sunlight – the violet blue area of the spectrum being the most effective. Exposing test tubes containing Pasteur’s solution to sunlight prevented the growth of microorganisms inside the tube and, upon increased exposure durations, the test tubes remained bacteria-free for several months.
These early investigations pointed to key factors that influence ultraviolet germicidal irradiation (UVGI):
- Inactivation of a given quantity of organisms is dependent on the dose of radiation received.
- Dose is the product of intensity and exposure duration.
- Inactivation is also dependent on the wavelength of the received radiation.
1889 – Widmark confirmed UV-C rays from arc lamps were responsible for microorganism inactivation.
1890 – Koch proved the lethal effect of sunlight on tuberculosis, which was an early indicator of the modern use of UV-C to combat this disease.
1892 – Geisler used a prism and heliostat to show that sunlight and electric arc lamps are lethal to Bacillus Typhosus.
1903 – Niels Ryberg Finsen (1860-1904) was awarded the Nobel Prize for Medicine, after being the first to employ UV-C rays in treating disease. He invented the Finsen curative lamp, which was used successfully through to the 1950s.
1903 – Banard and Morgan determined that a UV-C spectrum within 226-328 nm is biocidal.
1908 – UV-C was used to disinfect the municipal water supply of Marseille, France.
1930s – Westinghouse developed the first commercial UV-C germicidal lamps, which were used primarily in hospitals.
1932 – Ehris and Noethling isolated biocidal spectrum to 253.7 nm.
1933-1935 – William F. Wells showed that organisms in droplet expectoration could be killed in the air with UV-C.
1937-1941 – Wells showed that germicidal UV radiation in the upper section of the room prevented measles from spreading in public schools. However, there have been difficulties in replicating these findings.
Post World War II – UV-C (UV Cleaning Device) was used for sterilizing air in hospitals, kitchens, meat storage and processing plants, bakeries, breweries, dairies, beverage production, pharmaceutical plants and animal labs; anywhere microbiological contamination was a concern.
1950s – UV-C was incorporated into air handling equipment. It became a major component in the control and eradication of tuberculosis (TB) after Riley proved its effectiveness in 1957.
1960s – Concern about microbes decreased with the introduction and increasing availability of new drugs and sterilizing cleaners.
1970s – The energy crisis during this decade sparked enthusiasm for conservation. To save energy, heating, ventilating, and air-conditioning (HVAC) systems were shut down when not in use. Condensation that had previously been evaporated by the constantly moving air was now collecting on coils and drain pans. As a result, mold and other microorganisms multiplied in this dark, wet environment. When the Uv C Air Sanitizer Systems were re-started, microbial contaminants would circulate throughout the building.
1994 – The CDC acknowledged UV-C’s effectiveness for TB control.
1999 – The WHO recommended the use of UVGI for TB control.
2014 – UV-C was used as part of the final cleaning procedure within the Nebraska Biocontainment Unit upon Ebola patient discharge.
2020 – UV-C light was recommended for the disinfection of N95 masks and other PPE during SARS-CoV-2 pandemic.
Recent technological advancements have made it possible for UV-C disinfection technology to be used in an ever-expanding range of applications.
Through strategic partnerships with leading manufacturers, UV-C technology providers are uniquely positioned to present their customers with the best UV-C germicidal products to meet their specific needs.
APPENDIX C: References
Amoah, K., Craik, S., Smith, D. W. & Belosevic, M. (2005). Inactivation of Cryptosporidium oocysts and Giardia cysts by ultraviolet light in the presence of natural particulate matter. Journal of Water Supply, Research and Technology-Aqua, 54 (3): 165–178.
Ballester, N. A. & Malley, J. P. (2004). Sequential disinfection of adenovirus type 2 with UV-chlorine- chloramine. Journal American Water Works Association, 96(10): 97-103.
Batch, L. F., Schulz, C. R. & Linden, K. G. (2004). Evaluating water quality effects on UV disinfection of MS2 coliphage. Journal American Water Works Association, 96(7): 75-87.
Battigelli, D. A., Sobsey, M. D. & Lobe, D. C. (1993). The inactivation of Hepatitis A virus and other model viruses by UV irradiation. Water Science & Technology, 27(3-4): 339-342.
Belosevic, M., Craik, S. A., Stafford, J. L. Neumann, N. E., Kruithof, J. & Smith, D. W. (2001). Studies on the resistance/reaction of Giardia muris cysts and C. parvum oocysts exposed to medium-pressure ultraviolet radiation. FEMS Microbiology Letters, 204(1): 197-204.
Bolton J. R. & Linden, K. G. (2003). Standardization of Methods for Fluence (UV Dose) Determination in Bench-Scale UV Experiments. Journal of Environmental Engineering, 129(3): 209-216.
Boyce, J. M., Farrel, P. A.,Towle, D., Fekieta, R., & Aniskiewicz, M. (2016). Impact of Room Location on UV-C Irradiance and UV-C Dosage and Antimicrobial Effect Delivered by a Mobile UV-C Light Device. Infection Control Hospital Epidemiology, 37(6): 667-72.
Bukhari, Z., Abrams, F. & LeChevallier, M. (2004). Using ultraviolet light for disinfection of finished water. Water Science & Technology, 50(1): 173-178.
Caballero, S., Abad, F. X., Loisy, F., Le Guyader, F. S., Cohen, J., Pintó, R. M. & Bosch, A. (2004). Rotavirus virus-like particles as surrogates in environmental persistence and inactivation studies. Applied and Environmental Microbiology, 70(7): 3904-3909.
Cadnum, J. L., Tomas, M. E., Sankar, T., Jencson, A., Mathew, J. I., Kundrapu, S. & Donskey, C. J. (2016). Effect of Variation in Test methods on Performance of Ultraviolet-C Radiation Room Decontamination. Infection Control Hospital Epidemiology, 37(5): 555-60
Campbell, A. T. & Wallis, P. (2002). The effect of UV irradiation on human-derived Giardia lamblia cysts, Water Research, 36(4): 963-9.
Carlson, D. A., Seabloom, R. W., DeWalle, F. B., Wetzler, T. F., Engeset, J., Butler, R., Wangsuphachart, S. & Wang, S. (1985). Ultraviolet disinfection of water for small water supplies. US EPA Report No. EPA/600/S2-85/092.
Chang, J. C. H., Osoff, S. F., Lobe, D. C., Dorfman, M. H., Dumais, C. M., Qualls, R. G. & Johnson, J.D. (1985). UV. inactivation of pathogenic and indicator microorganisms. Applied and Environmental Microbiology, 49(6): 1361-1365.
Clancy, J. L., Bukhari, Z., Hargy, T. M., Bolton, J. R., Dussert, B. W. & Marshall, M. M. (2000). Using UV to inactivate Cryptosporidium – Even extremely low dosages of ultraviolet light can be highly effective for inactivating Cryptosporidium oocysts. Journal American Water Works Association, 92(9): 97-104.
Clancy, J. L., Marshall, M. M., Hargy, T. M. and Korich, D. G. (2004). Susceptibility of five strains of Cryptosporidium parvum oocysts to UV light. Journal American Water Works Association, 96(3): 84-93.
Craik, S. A., Finch, G. R., Bolton, J. R. & Belosevic, M. (2000). Inactivation of Giardia muris cysts using medium-pressure ultraviolet radiation in filtered water. Water Research, 34(18): 4325-4332.
Craik, S. A., Weldon, D., Finch, G. R., Bolton, J. R. & Belosevic, M. (2001). Inactivation of Cryptosporidium parvum oocysts using medium and low-pressure ultraviolet radiation. Water Research, 35(6): 1387-1398.
EPA 712-C-07-056 (2012). Product Performance Test Guidelines: OCSPP 810.2100 Sterilants–Efficacy Data Recommendations,
https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0150-0020
EPA 712-C-07-074 (2012). Product Performance Test Guidelines OCSPP 810.2200: Disinfectants for Use on Hard Surfaces—Efficacy Data Recommendations,
https://www.regulations.gov/document?D=EPA-HQ-OPPT-2009-0150-0021
Gerba, C. P., Gramos, D. M. & Nwachuku, N. (2002). Comparative inactivation of enteroviruses and adenovirus 2 by UV light. Applied and Environmental Microbiology, 68(10): 5167-5169.
Giese, N. & Darby, J. 2000. Sensitivity of microorganisms to different wavelengths of UV light: implications on modeling of medium pressure UV systems. Water Research, 34(16): 4007-4013.
Harris, G. D., Adams, V. D., Sorensen, D. L. & Curtis, M.S. (1987). Ultraviolet inactivation of selected bacteria and viruses with photoreactivation of the bacteria. Water Research, 21(6): 687-692.
Hayes, S. L., Rice, E. W., Ware, M. W. & Schaefer III, F. W. (2003). Low pressure ultraviolet studies for inactivation of Giardia muris cysts. J Applied and Environmental Microbiology, 94(1): 54-59.
Hijnen, W. A. M., Beerendonk, E. F. & Medema, G. J. (2006). Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water; a review. Water Research, 40(1): 3-22.
Hoyer, O. (1998). Testing performance and monitoring of UV systems for drinking water disinfection, Water Supply, 16(1-2): 424-429.
Huffman, D. E., Gennaccaro, A., Rose, J. B. & Dussert, B.W. (2002). Low- and medium-pressure UV inactivation of microsporidia Encephalitozoon intestinalis, Water Research, 36(12): 3161-3164.
Husman, A. M. D., Bijkerk, P., Lodder, W., Van den Berg, H., Pribil, W., Cabaj, A., Gehringer, P., Sommer, R. & Duizer, E. (2004). Calicivirus inactivation by nonionizing 253.7-nanometer-wavelength (UV) and ionizing (Gamma) radiation, Applied and Environmental Microbiology, 70(9): 5089-5093.
Johnson, A. M., Linden, K., Ciociola, K. M., De Leon, R., Widmer, G. & Rochelle, P. A. (2005). UV inactivation of Cryptosporidium hominis as measured in cell culture, Applied and Environmental Microbiology, 71(5): 2800-2802.
Joux, F., Jeffrey, W. H., Lebaron, P. & Mitchell, D. L. (1999). Marine bacterial isolates display diverse responses to UV-B radiation, Applied and Environmental Microbiology, 65(9): 3820-3827.
Karanis, P., Maier, W. A., Seitz, H. M. & Schoenen, D. (1992). UV sensitivity of protozoan parasites, Journal Water SRT-Aqua, 41(2): 95-100; 294-298.
Koganti, S., Alhmidi, H., Tomas, M. E., Cadnum, J. L., Jencson, A. & Donskey, C. J. (2016). Evalution of Hospital Floors as a Potential Source of Pathogen Dissemination Using a Nonpathogenic Virus as a Surrogate Marker, Infection Control & Hospital Epidemiology, Vol. 37(11): 1374-1377.
Lazarova, V. & Savoye, P. (2004). Technical and sanitary aspect of wastewater disinfection by ultraviolet irradiation for landscape irrigation, Water Science and Technology, 50(2): 203-209.
Liltved, H. & Landfald, B. (1996). Influence of liquid holding recovery and photoreactivation on survival of ultraviolet-irradiated fish pathogenic bacteria, Water Research, 30(5): 1109-1114.
Linden, K. G., Batch, L. & Schulz, C. (2002a). UV disinfection of filtered water supplies: water quality impacts on MS2 dose-response curves,
Proceedings American Water Works Association. Annual Conference, American Water Works Association, Denver, CO.
Linden, K. G., Shin, G. A., Faubert, G., Cairns, W. & Sobsey, M. D. (2002b). UV disinfection of Giardia lamblia cysts in water, Environmental Science & Technology, 36(11): 2519-2522.
Log Reduction graphic (2014). Courtesy of: https://www.bestsanitizers.com
Mamane-Gravetz, H. & Linden, K. G. (2004). UV disinfection of indigenous aerobic spores: Implications for UV reactor validation in unfiltered waters, Water Research, 38(12): 2898-2906.
Marshall, M. M., Hayes, S., Moffett, J., Sterling, C. R. & Nicholson, W. L. (2003). Comparison of UV inactivation of three Encephalitozoon species with that of spores of two DNA repair-deficient Bacillus subtilis biodosimetry strains, Applied and Environmental Microbiology, 69(1): 683-685.
Martin, E. L., Reinhardt, R. L., Baum, L. L., Becker, M. R., Shaffer, J. J. & Kokjohn, T. A. (2000). The effects of ultraviolet radiation on the moderate halophile Halomonas elongata and the extreme halophile Halobacterium salinarum, Canadian Jornal of Microbiology, 46(2): 180-187.
Maya, C., Beltran, N., Jimenez, B. & Bonilla, P. (2003). Evaluation of the UV disinfection process in bacteria and amphizoic amoebae inactivation, Water Science and Technology: Water Supply, 3(4): 285-291.
Meng, Q. S. & Gerba, C. P. (1996). Comparative inactivation of enteric adenoviruses, poliovirus and coliphages by ultraviolet irradiation, Water Research, 30(11): 2665-2668.
Mofidi, A. A., Meyer, E. A., Wallis, P. M., Chou, C. I., Meyer, B. P., Ramalingam, S. & Coffey, B. M. (2002). The effect of UV light on the inactivation of Giardia lamblia and Giardia muris cysts as determined by animal infectivity assay, Water Research, 36(8): 2098-2108.
Morita, S., Namikoshi, A., Hirata, T., Oguma, K., Katayama, H., Ohgaki, S., Motoyama, N. & Fujiwara, M. (2002). Efficacity of UV irradiation in inactivating C. parvum oocysts, Applied and Environmental Microbiology, 68(11): 5387-5393.
Nerandzic, M. M., Thota, P., Sankar, T., Jencson, A., Cadnum, J. L., Ray, A. J., Salata, R.A., Watkins, R. R. & Donskey, C. J., (2015). Evaluation of a Pulsed Xenon Ultraviolet Disinfection System for Reduction of Healthcare-Associated Pathogens in Hospital Rooms, Infection Control & Hospital Epidemiology, 36 (2): 192-197.
Nieuwstad, T. J. & Havelaar, A. H. (2008). The kinetics of batch ultraviolet inactivation of bacteriophage MS2 and microbiological calibration of an ultraviolet pilot plant, Journal of Environmental Science and Health, A29(9): 1993-2007.
Oguma, K., Katayama, H. & Ohgaki, S. (2002). Photoreactivation of E. coli after low- or medium- pressure UV disinfection determined by an endonuclease sensitive site assay, Applied and Environmental Microbiology, 68(12): 6029-6035.
Oguma, K., Katayama, H. & Ohgaki, S. (2004). Photoreactivation of Legionella pneumophila after inactivation by low or medium-pressure ultraviolet lamp, Water Research, 38(11): 2757-2763.
Oppenheimer, J. A., Hoagland, J. E., Laine, J. M., Jacangelo, J. G. & Bhamrah, A. (1993). Microbial inactivation and charcaterization of toxicity and by-products occurring in reclaimed wastewater disinfected with UV radiation, Conference on Planning, Design and Operation of Effluent
Disinfection Systems, Whippany, NJ, May 23-25, 1993, Water Environmental Federation Plan, Alexandria, VA.
Otaki, M., Okuda, A., Tajima, K., Iwasaki, T., Kinoshita, S. & Ohgaki, S. (2003). Inactivation differences of microorganisms by low pressure UV and pulsed xenon lamps, Water Science and Technology, 47(3): 185-190.
Rauth, A. M. (1965). The physical state of viral nucleic acid and the sensitivity of viruses to ultraviolet light, Biophysical Journal, 5(3): 257-273.
Rice, E. W. & Hoff, J. C. (1981). Inactivation of Giardia lamblia cysts by ultraviolet irradiation, Applied and Environmental Microbiology, 42(3): 546-547.
Shin, G. A., Linden, K. G. & Sobsey, M. D. (2000). Comparative inactivation of Cryptosporidium parvum oocysts and colliphage MS2 by monochromatic UV radiation, Proceedings of Disinfection 2000: Disinfection of Wastes in the New Millennium, New Orleans, Water Environment Federation, Alexandria, VA.
Shin, G. A., Linden, K.G., Arrowood, M. J. & Sobsey, M. D. (2001). Low-pressure UV inactivation and DNA repair potential of C. parvum oocysts, Applied and Environmental Microbiology, 67(7): 3029-3032.
Shin, G. A., Linden, K. G. & Sobsey, M. D. (2005). Low pressure ultraviolet inactivation of pathogenic enteric viruses and bacteriophages, Journal Environmental Engineering and Science, 4(S1): 4-36.
Sommer, R., Weber, G., Cabaj, A., Wekerle, J., Keck, G., & Schauberger, G. (1989). UV inactivation of micro- organisms in water. Zentralab Hyg. Umweltmed, 189(3): 214-224.
Sommer, R., Haider, T., Cabaj, A., Pribil, W. & Lhotsky, M. (1998). Time dose reciprocity in UV disinfection of water, Water Science and Technology, 38(12): 145-150.
Sommer, R., Cabaj, A., Sandu, T. & Lhotsky, M. (1999). Measurement of UV radiation using suspensions of microorganisms, J. Photochem. Photobiol., 53(1-3): 1-6.
Sommer, R., Lhotsky, M., Haider, T. & Cabaj, A. (2000). UV inactivation, liquid-holding recovery, and photoreactivation of E. coli O157 and other
pathogenic E. coli strains in water, Jornal of Food Protection, 63(8): 1015-1020.
Sommer, R., Pribil, W., Appelt, S., Gehringer, P., Eschweiler, H., Leth, H., Cabaj, A. & Haider, T. (2001). Inactivation of bacteriophages in water by means of non-ionizing (UV-253.7 nm) and ionizing (gamma) radiation: A comparative approach, Water Research, 35(13): 3109- 3116.
Thurston-Enriquez, J. A. , Haas, C. N. , Jacangelo, J. , Riley, K. & Gerba, C. P. (2003). Inactivation of feline calcivirus and adenovirus type 40 by UV radiation, Applied and Environmental Microbiology, 69(1): 577-582.
Thompson, S. S., Jackson, J. L., Suva-Castillo, M., Yanko, W. A., Jack, Z. E., Kuo, J., Chen, C. L., Williams, F. P. & Schnurr, D. P. (2003). Detection of infectious human adenoviruses in tertiary-treated and ultraviolet-disinfected wastewater, Water Environmental Research, 75(2): 163-170.
Tosa, K. & Hirata, T. (1998). HRWM-39: Photoreactivation of Salmonella following UV disinfection, IAWQ 19th Biennial International Conference, Vol. 10, Health- Related Water Microbiology.
Tosa, K. & Hirata, T. (1999). Photoreactivation of enterohemorrhagic E. coli following UV disinfection, Water Research, 33(2): 361-366.
Tree, J. A., Adams, M. R. & Lees, D. N. (1997). Virus inactivation during disinfection of wastewater by chlorination and UV irradiation and the efficacy of F+ bacteriophage as a ‘viral indicator’, Water Science and Technology, 35(11-12): 227-232.
Tree, J. A., Adams, M. R. & Lees, D. N. (2005). Disinfection of feline calicivirus (a surrogate for Norovirus) in wastewaters, Journal of Applied Microbiology, 98(1): 155-162.
Wiedenmann, A. , Fischer, B., Straub, U., Wang, C. H., Flehmig, B. & Schoenen, D. (1993). Disinfection of Hepatitis A virus and MS-2 coliphage in
water by ultraviolet irradiation: Comparison of UV-susceptibility, Water Science and Technology, 27(3-4): 335-338.
Wilson, B. R., Roessler, P. F., Van Dellen, E., Abbaszadegan, M. & Gerba, C. P. (1992). Coliphage MS-2 as a UV water disinfection efficacy test surrogate for bacterial and viral pathogens, Proceedings, Water Quality Technology Conference, Nov 15-19, 1992, Toronto, Canada, pp. 219-235, Amererican Water Works Association, Denver, CO.
Wu, Y., Clevenger, T. & Deng, B. (2005). Impacts of goethite particles on UV disinfection of drinking water, Appl. Environ. Microbiol., 71(7): 4140-4143.
Yaun, B.R., Sumner, S.S., Eifert, J.D. and Marcy, J.E. 2003. Response of Salmonella and E. coli O157:H7 to UV energy, J. Food Protection, 66(6): 1071-1073.
Zimmer, J.L. and Slawson, R.M. 2002. Potential repair of E. coli DNA following exposure to UV radiation from both medium- and low-pressure UV sources used in drinking water treatment, Applied and Environmental Microbiology, 68(7): 3293-3299.
Zimmer, J. L., Slawson, R. M. & Huck, P. M. (2003). Inactivation and potential repair of C. parvum following low- and medium-pressure ultraviolet irradiation, Water Research, 37(14): 3517-3523.
UV C Air Sanitizer – A Comprehensive Approach To Sanitization
UV-C, or ultraviolet C, is a type of ultraviolet light that has proven effective in eliminating various microorganisms, including bacteria, viruses, and mold. UV-C light works by disrupting the DNA and RNA of these pathogens, preventing them from reproducing and rendering them harmless. This technology has found widespread application in air purification systems, particularly in commercial spaces where maintaining a clean and healthy environment is paramount.
One of the key aspects of UV-C technology is irradiance, which refers to the amount of UV-C light that reaches a specific area. UV-C Irradiance is crucial in determining the effectiveness of an air sanitization system. High UV-C irradiance ensures that a sufficient dose of UV-C light is delivered to the air and surfaces, maximizing the system’s germicidal capabilities.
While UV-C technology has demonstrated its efficacy in ensuring a clean and sanitary atmosphere, it is important to note that these systems are designed for commercial use rather than residential applications. Businesses, healthcare facilities, and public spaces can benefit from the installation of UV-C irradiance devices to enhance overall hygiene.
These systems are strategically placed in areas where microbial contamination is a concern, contributing to a comprehensive approach to sanitation. By adopting UV-C irradiance in commercial spaces, businesses can provide a safer environment for employees and customers alike, showcasing a commitment to health and well-being. Invest in the power of UV-C irradiance for a cleaner, healthier commercial space.
The UV-C Air Sanitizer function by emitting short-wave ultraviolet light that disrupts the DNA and RNA of microorganisms, rendering them unable to reproduce and causing their demise. These devices are particularly effective against a wide range of pathogens, including bacteria, viruses, and mold spores, providing an added layer of protection against airborne contaminants.
UV cleaning devices in hospitals
Hospitals, with their stringent hygiene requirements, have been early adopters of UV-C technology. The UV cleaning device hospital play a vital role in preventing the spread of infections. These devices are strategically placed in critical areas such as operating rooms, patient rooms, and waiting areas to continuously sanitize the air and surfaces, creating a safer environment for patients, staff, and visitors.
While UV-C technology has proven its efficacy in healthcare settings, its benefits are not limited to hospitals. Commercial spaces, where foot traffic is high, and the risk of airborne transmission is a concern, can greatly benefit from the installation of UV-C Air Sanitizers.
When it comes to selecting the best UV-C Air Sanitizer for commercial spaces, it’s essential to consider factors such as irradiance, coverage area, and ease of installation. One standout product that meets these criteria is the [Product Name]. With its cutting-edge UV-C technology, this air sanitizer ensures high irradiance levels, providing thorough air purification for large commercial spaces.
Why so popular choice for commercial places?
While the benefits of UV-C Air Sanitizers are undeniable, it’s important to note that these systems are designed for commercial use and may not be suitable for residential settings. The primary reason for this distinction is the potential health risks associated with prolonged exposure to high levels of UV-C light. Commercial spaces can be optimized for the safe use of UV-C technology, with proper installation and maintenance carried out by professionals.
Installing the Best UV-C Air Sanitizer in a commercial setting involves careful planning to ensure optimal performance and safety. Professionals assess the space, determine the appropriate placement of the system, and conduct regular maintenance to guarantee its efficiency. These measures are crucial to safeguard occupants while maximizing the benefits of UV-C technology.
Understanding the importance of clean air
Understanding the importance of clean air goes beyond the technicalities of a device. It’s about creating environments that prioritize the health and well-being of everyone who enters the space. Imagine stepping into a commercial space where the air you breathe is not just fresh but has undergone a purification process, providing peace of mind and a sense of security.
UV-C Air Sanitizers are transforming the way we approach air purification in commercial spaces. With their ability to neutralize harmful microorganisms, these systems contribute to creating healthier environments for employees, customers, and visitors alike. As we continue to prioritize safety and well-being, investing in UV-C technology for commercial spaces is a step towards a cleaner and safer future.